Clinical feature	Statistical test	Significant genes	Associated with	&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;	Associated with	
Time to Death	Cox regression test	N=2929	shorter survival	N=1326	longer survival	N=1603
AGE	Spearman correlation test	N=4218	older	N=2062	younger	N=2156
PRIMARY SITE OF DISEASE	ANOVA test	N=17488	 	 	 	 
GENDER	t test	N=8361	male	N=3797	female	N=4564
KARNOFSKY PERFORMANCE SCORE	Spearman correlation test	N=1127	higher score	N=603	lower score	N=524
HISTOLOGICAL TYPE	ANOVA test	N=17230	 	 	 	 
PATHOLOGY T	Spearman correlation test	N=6063	higher pT	N=3246	lower pT	N=2817
PATHOLOGY N	Spearman correlation test	N=11	higher pN	N=3	lower pN	N=8
PATHOLOGICSPREAD(M)	ANOVA test	N=32	 	 	 	 
TUMOR STAGE	Spearman correlation test	N=7375	higher stage	N=3977	lower stage	N=3398
RADIATIONS RADIATION REGIMENINDICATION	t test	N=5965	yes	N=2978	no	N=2987
NEOADJUVANT THERAPY	t test	N=7746	yes	N=3927	no	N=3819
